Iatrogenic botulism cases after gastric and axillary application of botulinum toxin and review of literature.
Abstract
[INTRODUCTION] Iatrogenic botulism is a rare, serious disease that progresses with descending paralysis and develops after cosmetic or therapeutic botulinum toxin-A (BoNT-A) application.
[CASE PRESENTATIONS] In this case series; six cases of iatrogenic botulism followed up in our center are presented. Four of these developed after gastric BoNT-A and two after axillary BoNT-A application.
[RESULTS] The most important cause for the disease was the use of unlicensed products and high-dose toxin applications. The first symptoms were blurred vision, double vision, difficulty in swallowing, and hoarseness. Symptoms appeared within 4-10 days after the application of BoNT-A. Symptoms progressed in the course of descending paralysis in the following days with fatigue, weakness in extremities and respiratory distress. Diagnosis was based on patient history and clinical findings. The main principles of foodborne botulism therapy were applied in the treatment of iatrogenic botulism. If clinical worsening continued, regardless of the time elapsed after BoNT-A application, the use of botulinum antitoxin made a significant contribution to clinical improvement and was recommended.
[CONCLUSIONS] Routine and new indications for BoNT-A usage are increasing and, as a result, cases of iatrogenic botulism will be encountered more frequently. Physicians should be alert for iatrogenic botulism in the follow-up after BoNT-A applications and in the differential diagnosis of neurological diseases that are presented with similar findings.
[CASE PRESENTATIONS] In this case series; six cases of iatrogenic botulism followed up in our center are presented. Four of these developed after gastric BoNT-A and two after axillary BoNT-A application.
[RESULTS] The most important cause for the disease was the use of unlicensed products and high-dose toxin applications. The first symptoms were blurred vision, double vision, difficulty in swallowing, and hoarseness. Symptoms appeared within 4-10 days after the application of BoNT-A. Symptoms progressed in the course of descending paralysis in the following days with fatigue, weakness in extremities and respiratory distress. Diagnosis was based on patient history and clinical findings. The main principles of foodborne botulism therapy were applied in the treatment of iatrogenic botulism. If clinical worsening continued, regardless of the time elapsed after BoNT-A application, the use of botulinum antitoxin made a significant contribution to clinical improvement and was recommended.
[CONCLUSIONS] Routine and new indications for BoNT-A usage are increasing and, as a result, cases of iatrogenic botulism will be encountered more frequently. Physicians should be alert for iatrogenic botulism in the follow-up after BoNT-A applications and in the differential diagnosis of neurological diseases that are presented with similar findings.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 2 | |
| 합병증 | extremities
|
scispacy | 1 | ||
| 약물 | high-dose toxin
|
scispacy | 1 | ||
| 약물 | BoNT-A.
|
scispacy | 1 | ||
| 약물 | [INTRODUCTION]
|
scispacy | 1 | ||
| 약물 | high-dose
|
scispacy | 1 | ||
| 약물 | BoNT-A
→ botulinum toxin-A
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS] Routine
|
scispacy | 1 | ||
| 질환 | botulism
|
C0006057
Botulism
|
scispacy | 1 | |
| 질환 | paralysis
|
C0522224
Paralysed
|
scispacy | 1 | |
| 질환 | blurred vision
|
C0344232
Blurred vision
|
scispacy | 1 | |
| 질환 | hoarseness
|
C0019825
Hoarseness
|
scispacy | 1 | |
| 질환 | Symptoms
|
C0683368
Symptoms aspect
|
scispacy | 1 | |
| 질환 | fatigue
|
C0015672
Fatigue
|
scispacy | 1 | |
| 질환 | weakness
|
C0004093
Asthenia
|
scispacy | 1 | |
| 질환 | respiratory distress
|
C0476273
Respiratory distress
|
scispacy | 1 | |
| 질환 | neurological diseases
|
C0027765
nervous system disorder
|
scispacy | 1 | |
| 질환 | gastric
|
scispacy | 1 | ||
| 질환 | disease
|
scispacy | 1 | ||
| 질환 | gastric BoNT-A
|
scispacy | 1 | ||
| 기타 | axillary
|
scispacy | 1 | ||
| 기타 | botulinum toxin-A
|
scispacy | 1 | ||
| 기타 | BoNT-A
→ botulinum toxin-A
|
scispacy | 1 | ||
| 기타 | axillary BoNT-A
|
scispacy | 1 | ||
| 기타 | patient
|
scispacy | 1 | ||
| 기타 | botulinum antitoxin
|
scispacy | 1 |
MeSH Terms
Humans; Botulinum Antitoxin; Botulinum Toxins; Botulinum Toxins, Type A; Botulism; Clostridium botulinum; Iatrogenic Disease; Paralysis
📑 인용 관계
이 논문을 인용한 후속 연구 1
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.